DEF 14A: Erasca, Inc. Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Erasca, Inc. announces its annual stockholders meeting to be held virtually on June 20, 2024, to elect directors and ratify the appointment of its independent accounting firm.

Summary

• Erasca, Inc. will hold its Annual Meeting of Stockholders virtually on June 20, 2024, at 11:30 a.m. Pacific Time.
• Stockholders of record as of April 24, 2024, are entitled to vote.
• The meeting will address the election of two Class III directors for a three-year term expiring at the 2027 Annual Meeting.
• The meeting will also address the ratification of the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The Board recommends voting FOR the election of Jean I. Liu, J.D. and Pratik S. Multani, M.D. as Class III directors.
• The Board also recommends voting FOR the ratification of KPMG LLP as the independent accounting firm.
• As of the record date, April 24, 2024, there were 173,358,966 shares of common stock outstanding and entitled to vote.
• The proxy statement and the company's 2023 Annual Report are available online at www.proxydocs.com/ERAS.
• Stockholders can vote online, by phone, or by mail following the instructions provided in the proxy materials.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting factual information and recommendations. The sentiment is neutral to slightly positive due to the routine nature of the meeting and the company's adherence to corporate governance best practices.

Positives

• The company is adhering to SEC rules by providing proxy materials online, reducing costs and environmental impact.
• Stockholders have multiple options for voting: online, by phone, or by mail.
• The Audit Committee has pre-approved all audit and non-audit services provided by the independent registered public accounting firm.
• The company has a compensation recovery (clawback) policy in place.

Risks

• The division of the Board into three classes with staggered three-year terms may delay or prevent a change of management or a change in control of the company.
• Directors may be removed only for cause and only by the affirmative vote of the holders of at least two-thirds of the voting power of the then-outstanding shares of capital stock entitled to vote in the election of directors.

Future Outlook

The Board is not aware of any matter to be presented for action at the Annual Meeting other than the matters referred to above and does not intend to bring any other matters before the Annual Meeting. However, if other matters should come before the Annual Meeting, it is intended that holders of the proxies named on the Company's proxy card will vote thereon in their discretion.

Management Comments

• Jonathan E. Lim, M.D., Chairman, Chief Executive Officer, and Co-Founder, urges stockholders to promptly vote and submit their proxy.

Industry Context

This announcement is a routine part of corporate governance for publicly traded companies, ensuring stockholders have the opportunity to participate in key decisions.

Comparison to Industry Standards

• The virtual format of the annual meeting aligns with a growing trend among public companies to enhance accessibility and reduce costs.
• The director compensation program is designed to be competitive within the biopharmaceutical industry to attract and retain qualified board members.
• The company's corporate governance practices, including the establishment of key committees and a code of ethics, are consistent with Nasdaq listing requirements and industry best practices.
• The company's approach to ESG initiatives, including the Erasca Foundation and environmental efforts, reflects a growing emphasis on corporate social responsibility in the biotechnology sector.

Related Party Transactions

• The company has entered into indemnification agreements with each of its directors and executive officers.
• The company established the Erasca Foundation and made donations to it.

Stakeholder Impact

• Stockholders have the opportunity to vote on key decisions affecting the company's governance and financial oversight.
• Employees are impacted by the company's compensation and benefits policies, as well as its commitment to ethical conduct.
• The Erasca Foundation's initiatives benefit patients and communities affected by cancer.

Next Steps

• Stockholders are encouraged to review the proxy materials and vote their shares before the Annual Meeting.
• The company will announce preliminary voting results at the Annual Meeting and report the final results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Directors, KPMG, Stockholders, Voting, Governance, Erasca